A preview of this full-text is provided by Springer Nature.
Content available from The International Journal of Cardiovascular Imaging
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
1 3
The International Journal of Cardiovascular Imaging (2021) 37:3101–3114
https://doi.org/10.1007/s10554-021-02277-1
REVIEW PAPER
Lower extremity CT angiography inperipheral arterial disease:
fromtheestablished approach toevolving technical developments
OmarShwaiki1· BasemRashwan1· MatthiasA.Fink2· LevesterKirksey3· SameerGadani1·
KarunakaravelKaruppasamy1· ClaudiusMelzig2· DustinThompson1· GiuseppeD’Amico4· FabianRengier2·
SasanPartovi1
Received: 5 March 2021 / Accepted: 3 May 2021 / Published online: 17 May 2021
© The Author(s), under exclusive licence to Springer Nature B.V. 2021
Abstract
With the advent of multidetector computed tomography (CT), CT angiography (CTA) has gained widespread popularity for
noninvasive imaging of the arterial vasculature. Peripheral extremity CTA can nowadays be performed rapidly with high
spatial resolution and a decreased amount of both intravenous contrast and radiation exposure. In patients with peripheral
artery disease (PAD), this technique can be used to delineate the bilateral lower extremity arterial tree and to determine the
amount of atherosclerotic disease while differentiating between acute and chronic changes. This article provides an overview
of several imaging techniques for PAD, specifically discusses the use of peripheral extremity CTA in patients with PAD,
clinical indications, established technical considerations and novel technical developments, and the effect of postprocessing
imaging techniques and structured reporting.
Keywords CT angiography· Peripheral artery disease· Dual-energy CT· Structured reporting
Introduction
Peripheral artery disease (PAD) is defined as partial or com-
plete obstruction of any part of the peripheral arterial tree
and is typically associated with the lower extremities. PAD
represents the third leading cause of atherosclerotic mor-
bidity after coronary heart disease and stroke [1–3]. The
primary etiology associated with PAD is atherosclerosis, a
chronic inflammatory disease that leads to plaque forma-
tion, with the most relevant risk factors being advanced age,
smoking, and diabetes. Other well-established risk factors
are hypertension, male sex, Black ethnicity, hyperlipidemia,
and family history [4–7]. PAD has a high prevalence, occur-
ring in roughly one in ten individuals above the age of 55
and in up to one in seven individuals above the age of 70;
the prevalence has also increased over the past few decades,
presumably because of an aging population [3, 5, 6].
Most individuals with PAD are asymptomatic, and analy-
sis of several screening studies have found that the most fre-
quent sites of disease among asymptomatic individuals are
the iliac and femoral arteries, with femoropopliteal disease
being most common [8–10]. Some studies have suggested
that there may be an association between certain risk factors
and the anatomic distribution of disease [11, 12].
In patients with symptomatic PAD, the most common
symptoms are related to demand ischemia, the same process
underlying atherosclerotic manifestations in other parts of
the body. In the abdomen, PAD can manifest as mesenteric
ischemia, which can be diagnosed and treated with meth-
ods similar to those used for lower extremity PAD [13, 14].
Peripherally, PAD symptoms relate to claudication, with
disease progression leading to ulcer formation, impaired
wound healing, and even pain at rest. Routine screening for
PAD in asymptomatic individuals is not typically performed
and is generally reserved for those at high risk of the dis-
ease. The rationale behind not pursuing routine screening
* Sasan Partovi
sxp509@case.edu
1 Department ofInterventional Radiology, Cleveland Clinic
Main Campus, Cleveland, OH, USA
2 Section ofEmergency Radiology, Clinic forDiagnostic
andInterventional Radiology, University Hospital
Heidelberg, Heidelberg, Germany
3 Department ofVascular Surgery, Cleveland Clinic Main
Campus, Cleveland, OH, USA
4 Department ofTransplant Surgery, Cleveland Clinic Main
Campus, Cleveland, OH, USA
Content courtesy of Springer Nature, terms of use apply. Rights reserved.